---
document_datetime: 2024-11-27 11:51:35
document_pages: 23
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/hirobriz-breezhaler-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: hirobriz-breezhaler-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 43.2302378
conversion_datetime: 2025-12-15 21:50:03.541952
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Hirobriz Breezhaler

Proceduralstepstakenandscientificinformationaftertheauthorisation

| Application number   | Scope                                                                                                                                                                                                                     | Opinion/ Notification 1 issued on   | Commission Decision Issued2 / amended on   | Product Information affected3   | Summary   |
|----------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|--------------------------------------------|---------------------------------|-----------|
| IG/1807              | B.11.b.2.c.1-Change to importer,batch release arrangements and quality control testing of the FP - Replacementoradditionofamanufacturer responsibleforimportation and/orbatchrelease- Not including batch control/testing | 21/11/2024                          |                                            | Annex II and PL                 |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions areissuedfor all otherprocedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

2 A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet).The CD is issued within two months of the opinionfor variations falling under the scope of Article 23.1a(a)of Regulation(Eu)No.712/2012, or within oneyear for other procedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IG/1757            | A.7-Administrativechange-Deletionof manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                  | 14/06/2024   | n/a   |                                |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|--------------------------------|
| IG/1731            | B.II.b.1.a-Replacement or addition of a manufacturing site for the Fp - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                         | 19/03/2024   | n/a   |                                |
| IG/1664/G          | This was an application for a group of variations. A.4-Administrative change-Change in the name and/oraddressofamanufactureroranASMFholder orsupplieroftheAS，startingmaterial,reagentor intermediateused in themanufacture of theASor manufacturer of a novel excipient A.4-Administrative change-Change in the name and/oraddressofamanufactureror anASMFholder orsupplieroftheAS，startingmaterial,reagentor intermediateused in themanufactureof theASor manufacturerofanovelexcipient | 29/09/2023   | n/a   |                                |
| IB/0069/G          | This was an applicationfor a group of variations. B.I.a.2.a-Changes in the manufacturing process of theAS-Minor changein themanufacturingprocess oftheAS B.I.a.2.a-Changes in the manufacturingprocess of theAS-Minor change in the manufacturingprocess of the AS                                                                                                                                                                                                                       | 22/08/2023   | n/a   |                                |
| PSUSA/1730/ 202211 | PeriodicSafetyUpdateEUSingleassessment- indacaterol                                                                                                                                                                                                                                                                                                                                                                                                                                      | 06/07/2023   | n/a   | PRACRecommendation-maintenance |

<div style=\"page-break-after: always\"></div>

| This was an applicationfor a group ofvariations.                                                                                                                                                                                                                                                                                                 | 12/04/2023   | n/a        |                 | IG/1605/G   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|-------------|
| B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier)-Replacementoradditionofasupplier                                                                                                                                                                                                              | 17/05/2022   | n/a        |                 | IG/1513     |
| B.II.e.6.b - Change in any part of the (primary) packagingmaterial notincontactwith thefinished product formulation - Change that does not affect theproductinformation                                                                                                                                                                          | 22/11/2021   | n/a        |                 | IG/1452     |
| A.4-Administrative change-Change in thename and/oraddressof amanufactureroranASMFholder orsupplieroftheAS，startingmaterial,reagentor intermediateusedinthemanufactureof theASor manufacturerofanovelexcipient                                                                                                                                    | 10/08/2021   | n/a        |                 | IG/1428     |
| This was an applicationfor a group of variations. A.5.b-Administrative change-Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excludingmanufacturerforbatchrelease) B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - | 06/08/2021   | 29/11/2021 | Annex II and PL | IG/1424/G   |

<div style=\"page-break-after: always\"></div>

| Replacementoradditionofamanufacturer responsible for importation and/or batch release - Notincludingbatchcontrol/testing                                                                                                                                                                                                                                                                                                                             |            |            |                                  |           |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------|
| B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier                                                                                                                                                                                                                                                                                                                          | 12/02/2021 | n/a        |                                  | IG/1357   |
| A.4-Administrative change -Change in the name and/oraddressofamanufactureroranASMFholder orsupplieroftheAS，startingmaterial,reagentor intermediateusedinthemanufactureoftheASor manufacturerofanovelexcipient                                                                                                                                                                                                                                        | 08/01/2021 | n/a        |                                  | IG/1309   |
| This was an application for a variation following a worksharing procedure according to Article 20 of CommissionRegulation(EC)No1234/2008. C.I.z-Changes(Safety/Efficacy)of Human and VeterinaryMedicinalProducts-Othervariation                                                                                                                                                                                                                      | 10/12/2020 | 29/11/2021 | SmPC, Annex I1, Labelling and PL | WS/1931   |
| Thiswasanapplicationforagroupofvariations. B.II.c.3.z-Change in source of an excipient or reagent with TSE risk - Other variation B.IIl.1.b.2-Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/orexcipientfroma new or an already approved manufacturer B.II1.1.b.2-Submission of a new/updated or deletion ofPh.Eur.TSE Certificate ofSuitability- | 21/07/2020 | n/a        |                                  | IG/1271/G |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|                    | New certificate for a starting material/reagent/intermediate/orexcipientfroma new or an already approved manufacturer B.III.1.b.2-Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/orexcipientfroma new or an already approved manufacturer B.IIl.1.b.2-Submission of a new/updated or deletion ofPh.Eur.TSE Certificate of Suitability- New certificate for a starting material/reagent/intermediate/orexcipientfroma neworanalreadyapprovedmanufacturer B.III.1.b.2-Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - New certificate for a starting material/reagent/intermediate/orexcipientfroma new or an already approved manufacturer B.III.1.b.3-Submission of a new/updated or deletion ofPh.Eur.TSE Certificate of Suitability- Updatedcertificatefromanalreadyapproved manufacturer B.II1.1.b.4-Submission of a new/updated or deletion ofPh.Eur.TSE Certificate ofSuitability- Deletion of certificates(in casemultiple certificates   |            |     |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| PSUSA/1730/ 201911 | PeriodicSafetyUpdateEUSingle assessment- indacaterol                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 09/07/2020 | n/a |
| IG/1229            | A.7-Administrativechange-Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 13/03/2020 | n/a |

<div style=\"page-break-after: always\"></div>

| IG/1192/G   | This was an application for a group of variations. A.7-Administrativechange-Deletionof manufacturing sites B.11.b.2.c.1-Change to importer,batch release arrangements and quality control testing of the FP - Replacementoradditionofamanufacturer responsible for importation and/or batch release - Notincludingbatchcontrol/testing   | 28/01/2020   | 14/12/2020   | Annex II and PL        |                              |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|------------------------|------------------------------|
| WS/1708     | This was an application for a variation following a worksharingprocedureaccordingtoArticle20of CommissionRegulation(EC)No1234/2008. C.I.z - Changes (Safety/Efficacy) of Human and VeterinaryMedicinalProducts-Othervariation                                                                                                            | 12/12/2019   | 14/12/2020   | SmPC, Labelling and PL |                              |
|             | Thiswas an applicationfor a group of variations. A.7-Administrative change-Deletion of manufacturing sites A.7-Administrativechange-Deletionof                                                                                                                                                                                           | 12/03/2019   | n/a          |                        | IG/1073/G manufacturingsites |
|             | Thiswas an applicationfor a group of variations. B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products                                               | 16/11/2018   | n/a          |                        | IB/0053/G                    |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|           | B.II.b.2.a-Change to importer,batch release arrangements and quality control testing of the FP - Replacement/additionofasitewherebatch control/testingtakesplace B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in themanufacturingprocess                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |     |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| WS/1440/G | Thiswas anapplicationfor agroupofvariations following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.I.b.1.b-Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent-Tightening of specification limits B.I.b.1.b-Change in the specificationparameters and/or limits of an AS, starting material/intermediate/reagent-Tighteningof specification limits B.I.b.1.c-Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent-Additionofanew specification parameter to the specification with its corresponding test method B.I.b.2.a-Change in testprocedure forAS or startingmaterial/reagent/intermediate-Minor changes to an approved test procedure B.I.b.1.b -Change in the specification parameters and/or limits of an AS, starting | 13/09/2018 | n/a |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |            |            |                                  | specification limits   |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|------------------------|
| IA/0052   | C.I.z-Changes(Safety/Efficacy)of Human and VeterinaryMedicinalProducts-Othervariation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 23/08/2018 | 01/08/2019 | SmPC, Annex I1, Labelling and PL |                        |
| IB/0051/G | Thiswasanapplicationfor agroupofvariations. B.II.a.3.b.6-Changesinthecomposition (excipients) of the finished product - Other excipients -Replacementofa single excipientwith a comparableexcipientwiththe samefunctional characteristicsand atasimilarlevel B.II.d.2.a - Change in test procedure for the finished product-Minorchangestoanapprovedtest procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a-Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a-Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure | 24/07/2018 | n/a        |                                  |                        |

<div style=\"page-break-after: always\"></div>

| product-Minor changesto an approved test                                                                                                                                                                                                                                                                                                                                              |            |            |                        | procedure                                     |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------------------|
| TransferofMarketingAuthorisation                                                                                                                                                                                                                                                                                                                                                      | 26/03/2018 | 06/07/2018 | SmPC, Labelling and PL | T/0047                                        |
| A.5.b - Administrative change - Change in the name and/oraddressofamanufacturer/importerofthe finishedproduct,including qualitycontrol sites (excluding manufacturerforbatchrelease)                                                                                                                                                                                                  | 18/06/2018 | n/a        |                        | IG/0950                                       |
| This was an applicationfor a group of variations. B.II1.1.b.3-Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Updatedcertificatefrom analready approved manufacturer B.III.1.b.4-Submission of a new/updated or deletion of Ph. Eur. TSE Certificate of Suitability - Deletion of certificates (in case multiple certificates existper material) | 26/04/2018 | n/a        |                        | IG/0927/G                                     |
| Minorchangeinlabellingorpackageleafletnot connectedwiththeSPC(Art.61.3Notification)                                                                                                                                                                                                                                                                                                   | 22/03/2018 | 06/07/2018 | PL                     | N/0046                                        |
| This was an application for a group of variations following a worksharing procedure according to Article 20of CommissionRegulation(EC)No 1234/2008.                                                                                                                                                                                                                                   | 14/12/2017 | n/a        |                        | WS/1254/G A.7-Administrativechange-Deletionof |

<div style=\"page-break-after: always\"></div>

|                    | manufacturing sites B.I.a.1.a - Change in the manufacturer of AS or of a startingmaterial/reagent/intermediateforAS-The proposedmanufacturerispartofthesame pharmaceutical group as the currently approved manufacturer B.I.a.1.g - Change in the manufacturer of AS or of a startingmaterial/reagent/intermediateforAS- Introductionofanewmanufacturer of theASthatis not supported by an ASMF and requires significant updateto therelevantASsectioninthedossier   |            |            |           |                                                                                                                                       |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------|---------------------------------------------------------------------------------------------------------------------------------------|
| IG/0879            | A.7-Administrativechange-Deletionof manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                              | 11/12/2017 | n/a        |           |                                                                                                                                       |
| N/0044             | Minor change in labelling or package leaflet not connected with theSPC(Art.61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                        | 06/11/2017 | 06/07/2018 | Labelling |                                                                                                                                       |
| PSUSA/1730/ 201611 | Periodic Safety Update EU Single assessment - indacaterol                                                                                                                                                                                                                                                                                                                                                                                                            | 20/07/2017 | 26/09/2017 | Annex II  | Refer to Scientific conclusions and grounds recommending thevariation to terms of theMarketingAuthorisation(s)'for PSUSA/1730/201611. |
| IG/0784/G          | This was an application for a group of variations. B.II.c.1.a - Change in the specification parameters and/or limits of an excipient -Tightening of specification limits B.II.c.1.a-Change in the specificationparameters and/or limits of an excipient - Tightening of specification limits                                                                                                                                                                         | 31/03/2017 | n/a        |           |                                                                                                                                       |

<div style=\"page-break-after: always\"></div>

|         | B.II.c.1.b - Change in the specification parameters and/orlimitsofanexcipient-Additionofanew specification parameter to the specification with its corresponding test method B.II.c.2.a-Change in test procedure for an excipient - Minor changes to an approved test procedure B.II.c.2.a - Change in test procedure for an excipient - Minor changes to an approved test procedure B.III.2.z-Change to comply with Ph.Eur.orwith a nationalpharmacopoeiaofaMemberState-Other   |            |            |      | specification limits variation   |
|---------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|----------------------------------|
| WS/1102 | This was an application for a variation following a worksharingprocedureaccordingtoArticle20of CommissionRegulation(EC)No1234/2008. B.II.f.1.b.1-Stability of FP-Extension of the shelf life of the finished product - As packaged for sale (supported byreal time data)                                                                                                                                                                                                         | 23/02/2017 | 26/09/2017 | SmPC |                                  |
|         | A.5.b-Administrative change -Change in the name and/or addressofamanufacturer/importerofthe finishedproduct,includingqualitycontrolsites (excludingmanufacturerforbatchrelease)                                                                                                                                                                                                                                                                                                  | 03/08/2016 | n/a        |      | IG/0712                          |
|         | This was an application for a variation following a worksharing procedure according to Article 20 of CommissionRegulation(EC)No1234/2008. TheMAHsubmitted thefinal studyreportofUSPASS                                                                                                                                                                                                                                                                                           | 23/06/2016 | n/a        |      | WS/0944                          |

<div style=\"page-break-after: always\"></div>

|           | update to fulfil MEA017/MEA015/MEA015 for Onbrez Breezhaler(EMEA/H/C/1114)and duplicate authorizationsHirobrizBreezhaler(EMEA/H/C/1211) andOslifBreezhaler(EMEA/H/C/1210).Therevisions of the RMP were also accepted (version 9.0) reflectingtheresultsfromthisstudy and its completion. C.I.13 - Other variations not specifically covered elsewhere in thisAnnexwhich involve the submission of studies to the competent authority                                                                                                                                                                                                                   |            |     |                                                    |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------------------------------------|
| WS/0777/G | Thiswasanapplicationfor agroupofvariations followingaworksharingprocedure accordingto Article20ofCommissionRegulation(EC)No 1234/2008. Submissionof thefinal studyreportsof2PASS studies(UKPASSstudy QAB149B2431/QAB149AS232863)included inthe RMPtomonitor off-labeluseof indacaterolinasthma patients and to monitor specified safety risks among initiatorsofindacaterolrelativetoinitiatorsofother long-actingbeta2-agonists(LABA)medicationsfor theCOPDindication;an updated RMP(version8.1) has been submitted. Additionally, the MAH took the opportunity to amend the RMP in line with the conclusions of previous assessment of RMP measures. | 23/07/2015 | n/a | C.I.13 - Other variations not specifically covered |

<div style=\"page-break-after: always\"></div>

|           | elsewhere in thisAnnexwhich involve the submission of studies to the competent authority C.I.13-Other variations not specifically covered elsewherein thisAnnexwhichinvolvethesubmission ofstudiestothecompetentauthority C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation,including theRMP-Othervariation   |            |            |                        |                                                                                                                |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------------------------------------------------------------------------------------------|
| IB/0035/G | This was an application for a group of variations. C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation,including theRMP-Othervariation C.1.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation，includingtheRMp-Othervariation                                  | 10/02/2015 | n/a        |                        |                                                                                                                |
| IG/0484/G | This wasan applicationfor a group of variations. A.7-Administrative change-Deletion of manufacturingsites B.II.b.1.a-Replacement or addition of a manufacturing site for the Fp -Secondary packaging site                                                                                                                                                            | 12/11/2014 | n/a        |                        |                                                                                                                |
| IG/0488   | A.1 -Administrative change - Change in the name and/oraddressof theMAH                                                                                                                                                                                                                                                                                               | 13/10/2014 | 08/09/2015 | SmPC, Labelling and PL |                                                                                                                |
| R/0030    | Renewal of the marketing authorisation.                                                                                                                                                                                                                                                                                                                              | 24/07/2014 | 18/09/2014 | SmPC, Labelling and    | Based on the review of data on quality, safety and efficacy theCHMPconsidered thattherisk-benefitbalanceof the |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |     | PL   | product in the maintenance bronchodilator treatment of airflowobstruction in adultpatientswith COPDremains favourableandthereforerecommendedtherenewalofthe marketing authorisation.TheCHMPrecommended thatthe renewal be granted with unlimited validity.   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0032   | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation,includingtheRMP-Othervariation                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 29/07/2014 | n/a |      |                                                                                                                                                                                                                                                              |
| PSUV/0031 | PeriodicSafetyUpdate                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 13/06/2014 | n/a |      | PRACRecommendation-maintenance                                                                                                                                                                                                                               |
| IB/0029   | B.II.b.3.z-Change in the manufacturing process of thefinishedorintermediateproduct-Othervariation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 12/03/2014 | n/a |      |                                                                                                                                                                                                                                                              |
| IG/0389/G | This was an application for a group of variations. B.II.a.1.a - Change or addition of imprints, bossing orothermarkingsincludingreplacement,oraddition ofinksusedforproductmarking-Changesin imprints, bossing or other markings B.II.b.1.b-Replacement or addition of a manufacturing site for the FP - Primary packaging site B.II.b.2.a-Change to importer,batchrelease arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testingtakesplace A.7-Administrativechange-Deletionof manufacturing sites A.7-Administrativechange-Deletionof | 20/12/2013 | n/a |      |                                                                                                                                                                                                                                                              |

<div style=\"page-break-after: always\"></div>

|           | A.5.b-Administrative change -Change in the name and/or addressofamanufacturer/importerofthe finished product, including quality control sites (excludingmanufacturerforbatchrelease)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |            |            |      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0375/G | Thiswas anapplicationfor agroupofvariations. A.7-Administrative change-Deletion of manufacturing sites A.7-Administrative change-Deletion of manufacturingsites A.5.b-Administrative change-Change in the name and/oraddressofamanufacturer/importerofthe finishedproduct,including quality control sites (excludingmanufacturerforbatchrelease)                                                                                                                                                                                                                                                                                                                                        | 25/11/2013 | n/a        |      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| WS/0455   | Thiswasanapplicationforavariationfollowinga worksharingprocedureaccordingtoArticle20of CommissionRegulation(EC)No1234/2008. Updateofsection4.2oftheSmPCinorder todraw theprescriber'sattentiontothepossibilityofpatients swallowingthecapsulesinsteadofinhalingthe product asfurtherriskminimisationfortheriskof \"medicationerror\"，followingarequestfromthe CHMPandinordertofulfilRMP014.Theformatof the outer and immediate outer packaging was updated accordingly without affecting the labelling text.Inadditionsection4.5of theSmPChasbeen updated tobringit inline withsection12partVRisk minimisationmeasuresoftheRMPregarding therisk of lesseffectof\"beta-adrenergicblockers\". | 21/11/2013 | 18/09/2014 | SmPC | Following the assessment of indacaterol RMP 014 (version 7.0of theRMP),theMAH wasrequested bytheCHMPto insert\"medication error\"as animportant identified risk in theRMP and toproposefurtherriskminimization measures.TheMAHwasalsorequestedtorevisetheouter package so that the information\"Do not swallow capsules\"\" and\"Forinhalation use only\"is emphasized e.g.by includingaredrelativelybroadboxaroundthetextandby perhaps changing the font size. This variation led to an updateofsection4.2of theSmPC and theouter and immediate packaging accordingly. In addition section 4.5 of theSmPC hasbeenupdated tobringit in line withsection 12partVRiskminimisationmeasuresoftheRMPregarding the risk of less effectof\"beta-adrenergicblockers\". |

<div style=\"page-break-after: always\"></div>

|           | C.I.z - Changes (Safety/Efficacy) of Human and VeterinaryMedicinalProducts-Othervariation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |            |                       |                                                                                                                             |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|-----------------------------------------------------------------------------------------------------------------------------|
| IG/0369/G | This was an applicationfor a group of variations. B.II.a.4.a - Change in coating weight of oral dosage formsorchangeinweightofcapsuleshells-Solid oralpharmaceuticalforms B.II.d.2.a-Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a-Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.II.d.2.a-Change in test procedure for the finished product - Minor changes to an approved test | 20/11/2013 | n/a        |                       |                                                                                                                             |
| PSUV/0023 | PeriodicSafety Update                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 27/06/2013 | 26/08/2013 | SmPC, Annex II and PL | Refer to Scientific conclusions and grounds recommending thevariation totermsof theMarketingAuthorisation(s)'for PSUV/0023. |
| IG/0336/G | Thiswas an applicationfor a group of variations. B.II.b.1.b-Replacement or additionof a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 15/08/2013 | n/a        |                       |                                                                                                                             |

<div style=\"page-break-after: always\"></div>

|           | manufacturing site for the Fp - Primary packaging site B.II.b.2.a-Change tobatchrelease arrangements andqualitycontrol testingoftheFP-Replacement or addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                         |            |     |                                 |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|---------------------------------|
| IB/0020/G | Thiswas an applicationfor a group of variations. B.II.e.7.z. - Change in supplier of packaging componentsor devices(whenmentioned in the dossier) - Other variation B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier)-Replacement or additionofasupplier B.II.e.7.a-Change in supplier of packaging components ordevices(when mentioned in the dossier)- Deletion of a supplier B.II.e.7.a - Change in supplier of packaging components ordevices(whenmentioned in the | 17/07/2013 | n/a | dossier)-Deletion of a supplier |
| IB/0021   | B.II.b.3.z-Change in the manufacturing process of thefinishedproduct-Othervariation                                                                                                                                                                                                                                                                                                                                                                                                                                     | 02/07/2013 | n/a |                                 |
|           | This was an application for a group of variations. B.III.1.b.2- Submission of a new or updated Ph.Eur. TSECertificateofsuitability-Newcertificatefora startingmaterial/reagent/intermediate/orexcipient fromanewor analreadyapprovedmanufacturer B.III.1.b.3-Submission of a new or updated Ph.Eur.                                                                                                                                                                                                                     | 24/06/2013 | n/a | IG/0315/G                       |

<div style=\"page-break-after: always\"></div>

|           | TSECertificateofsuitability-Updatedcertificate from an alreadyapprovedmanufacturer                                                                                                                                                                                                                                                                                                                                                                        |            |            |                        |                                                                                                                                                                                                                                                                                                                                                                |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IG/0248   | C.I.z - Changes (Safety/Efficacy) of Human and VeterinaryMedicinalProducts-Othervariation                                                                                                                                                                                                                                                                                                                                                                 | 17/12/2012 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                |
| IG/0209/G | This was an application for a group of variations. C.I.9.b-Changestoanexistingpharmacovigilance system as described in the DDPS - Change in the contact details of the QPPV C.I.9.h-Changes toanexistingpharmacovigilance system as described in the DDPS - Other change(s) totheDDPSthatdoesnotimpactontheoperationof the pharmacovigilance system                                                                                                       | 17/08/2012 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                |
| IG/0204   | B.II.a.1.a - Change or addition of imprints, bossing or other markings including replacement, or addition of inks used for product marking-Changes in imprints,bossing or other markings                                                                                                                                                                                                                                                                  | 08/08/2012 | n/a        |                        |                                                                                                                                                                                                                                                                                                                                                                |
| 11/0015   | UponrequestfromtheCHMPfollowingthe assessmentofthePSuR,thelist andfrequenciesof adversereactionsintheSmPCsection4.8havebeen updated based on additional data obtained post- marketing.A warning about hypersensitivity reactionshasbeenaddedtoSmPCsection4.4.In addition, two pictures illustrating the use of the inhaler device have been updated in the SmPC and PL.Also theSmPC,AnnexII, labelling andPLhave been updated to the latest QRD template. | 21/06/2012 | 03/08/2012 | SmPC, Labelling and PL | Basedonreviewofpooledsafetydatafrom11phaseII studies with treatment duration of 12 weeks or longer, including4,746patientsexposedtoindacaterolupto600 microgram once-daily, the list and frequencies of adverse reactions in the SmPC has been revised. For the newly included hypersensitivity reactions, a corresponding warninghasbeen included in theSmPC. |

<div style=\"page-break-after: always\"></div>

|           | C.I.4-Variations related to significant modifications of theSPC dueinparticular to newquality,pre- clinical, clinical orpharmacovigilance data                                                                                                                                                                                                                                                                                                                                                                   |            |     |                                        |
|-----------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----------------------------------------|
| IG/0194/G | Thiswasanapplicationfor agroupofvariations. B.I.a.1.f-Change in themanufacturer of ASor of a startingmaterial/reagent/intermediateforAS- Changestoqualitycontroltesting arrangementsfor theAS-replacement or additionofasitewhere batch control/testing takes place B.1.b.1.b-Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Tightening of specification limits B.I.b.2.a-Change in test procedure forAS or startingmaterial/reagent/intermediate-Minor | 12/07/2012 | n/a | changes to an approved test procedure  |
|           | Thiswas an applicationfor a group of variations. C.I.9.e-Changes to an existingpharmacovigilance system as described in the DDPS - Changes in the major contractual arrangements with other persons ororganisationsinvolvedinthefulfilmentof pharmacovigilanceobligationsanddescribedinthe DD C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of                                                          | 22/02/2012 | n/a | IG/0148/G the pharmacovigilance system |

<div style=\"page-break-after: always\"></div>

| IG/0139/G   | Thiswas an applicationfor a groupofvariations.                                                                                                                                                                                                                                                                                                                                           | 16/12/2011   | n/a   |           |
|-------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------|
|             | Thiswas anapplicationfor a group of variations. B.III.1.b.3-Submission of a new or updated Ph.Eur. TSE Certificate of suitability -Updated certificate from an already approved manufacturer B.IIl.1.b.3-Submission of a new or updated Ph.Eur. TSECertificate ofsuitability-Updatedcertificate from an already approved manufacturer                                                    | 11/11/2011   | n/a   | IG/0113/G |
|             | This was an applicationfor a group of variations. C.I.9.e-Changes to anexistingpharmacovigilance system as described in the DDPS - Changes in the majorcontractualarrangementswithotherpersons ororganisationsinvolvedinthefulfilmentof pharmacovigilanceobligationsanddescribedinthe DD C.I.9.h-Changes toanexistingpharmacovigilance system as described in the DDPS - Other change(s) | 11/07/2011   | n/a   | IG/0088/G |

<div style=\"page-break-after: always\"></div>

|           | totheDDPSthatdoesnotimpactontheoperationof the pharmacovigilance system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |            |     |    |                                                                                           |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----|-------------------------------------------------------------------------------------------|
| N/0007    | Minor change in labelling or package leaflet not connected with theSPC(Art.61.3Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           | 31/05/2011 | n/a | PL | Update of the local representatives contact details in Italy, Cyprus, Poland and Romania. |
| IG/0032/G | This was an application for a group of variations. Toupdate theDetailedDescriptionof the PharmacovigilanceSystem(DDPS)toversion9.0,to include: -a changeinthedeputyof theQualifiedPersonfor Pharmacovigilance (QPPV); - a change in the major contractual arrangements. - administrative changes not impacting the operation of the pharmacovigilance system. AnnexII.Bhasalsobeenupdatedwith thelatest wording as per October 2010 CHMPprocedural announcement. C.I.9.c-Changes to an existingpharmacovigilance system as described in the DDPS - Change of the back-upprocedureoftheQPPV C.I.9.e - Changes to an existing pharmacovigilance system as described in the DDPS - Changes in the major contractual arrangements with other persons or organisations involved in the fulfilment of pharmacovigilanceobligations anddescribedinthe DD C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) | 21/12/2010 | n/a |    |                                                                                           |

<div style=\"page-break-after: always\"></div>

|         | the pharmacovigilance system                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |            |                       |                                                 |
|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|-------------------------------------------------|
| IB/0005 | C.I.3.a - Implementation of change(s) requested following the assessment of an USR, class labelling, a PSUR,RMP,FUM/SO,datasubmittedunderA45/46， oramendmentstoreflectaCoreSPC-Changeswith NOnewadditionaldataaresubmittedbytheMAH                                                                                                                                                                                                                                                                                                                | 16/12/2010 | n/a        | SmPC, Annex II and PL |                                                 |
|         | This was an applicationfor a group of variations. B.Ill.1.b.2-Submissionof anewor updatedPh.Eur. TSECertificateofsuitability-Newcertificatefora startingmaterial/reagent/intermediate/orexcipient fromanewor an alreadyapprovedmanufacturer B.III.1.b.2 - Submission of a new or updated Ph.Eur. TSECertificateofsuitability-Newcertificatefora startingmaterial/reagent/intermediate/orexcipient from a new or analready approved manufacturer B.II1.1.b.3-Submission of a new or updated Ph.Eur. TSECertificateofsuitability-Updatedcertificate | 20/10/2010 | n/a        |                       | IG/0025/G from an already approved manufacturer |
| WS/0024 | This was an application for a variation following a worksharingprocedureaccordingtoArticle20of CommissionRegulation(EC)No1234/2008. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changestoatestprocedure(includingreplacement or addition) for the AS or a starting material/intermediate                                                                                                                                                                                                        | 23/09/2010 | 23/09/2010 |                       |                                                 |

<div style=\"page-break-after: always\"></div>

| IA/0004   | A.6-Administrative change-Change inATC Code/ATCVetCode                                                                                                                                                                                                                  | 16/06/2010   | n/a        | SmPC     |                                                                                                                                                                                                                                                                                                                                                   |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| I1/0001   | Update of the Detailed Description of the Pharmacovigilance system(DDPS). Changes to QPPV UpdateofDDPS(Pharmacovigilance)                                                                                                                                               | 18/02/2010   | 26/03/2010 | Annex II | WiththisvariationtheMAHsubmittedanewversionofthe DDPS(core version 8.0 andproduct specificversion5.0)in accordance with the currentPharmacovigilance guideline. Afterassessing thedocumentationtheCHMPconcluded thatthesubmittedDDPScontained all requiredelements. Consequently,Annex IIhasbeenupdatedwith the new versionnumberoftheagreedDDPS. |
| IB/0003   | Toextendfrom18monthsto24monthstheshelf life of the product IB_42_a_01_Change in shelf-life of finished product - as packaged for sale                                                                                                                                   | 26/01/2010   | n/a        | SmPC     |                                                                                                                                                                                                                                                                                                                                                   |
| IA/0002   | ToaddKonapharmaAG,ImWannenbodenasan additionnal manufacturing site for primary and secondarypackagingactivities IA_o7_a_Replacement/add.ofmanufacturingsite: Secondary packaging site IA_07_b_01_Replacement/add. of manufacturing site:Primarypackagingsite-Solidforms | 21/12/2009   | n/a        |          |                                                                                                                                                                                                                                                                                                                                                   |